Akebia Therapeutics Inc (NASDAQ:AKBA)
| 0.3818 Delayed Data As of 5:19pm ET |  +0.0304 / +8.65%Today’s Change | 0.30 Today|||52-Week Range 4.09 | -83.11% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Butler John P President & Chief Executive Officer |  Sale | 3/01/2022 | 25,031 | $2.17 | $54.3K | -83.71% |
Butler John P President & Chief Executive Officer | Sale | 2/28/2022 | 25,053 | $2.15 | $53.9K | -83.78% |
Butler John P President & Chief Executive Officer | Sale | 3/01/2022 | 24,811 | $2.17 | $53.8K | -83.71% |
Spellman David A Chief Financial Officer & Senior Vice President | Sale | 2/28/2022 | 7,400 | $2.15 | $15.9K | -83.78% |
Burke Steven K Chief Medical Officer & Senior Vice President | Sale | 2/28/2022 | 7,400 | $2.15 | $15.9K | -83.78% |
Hadas Nicole R Chief Legal Officer & Senior Vice President | Sale | 3/01/2022 | 6,873 | $2.17 | $14.9K | -83.71% |
Dahan Michel /inspiration/ Chief Operating Officer & Senior Vice President | Sale | 3/01/2022 | 6,873 | $2.17 | $14.9K | -83.71% |
Dahan Michel /inspiration/ Chief Operating Officer & Senior Vice President | Sale | 3/01/2022 | 6,873 | $2.17 | $14.9K | -83.71% |
Hadas Nicole R Chief Legal Officer & Senior Vice President | Sale | 3/01/2022 | 6,556 | $2.17 | $14.2K | -83.71% |
Burke Steven K Chief Medical Officer & Senior Vice President | Sale | 3/01/2022 | 6,556 | $2.17 | $14.2K | -83.71% |
Page of 4